AI-Driven Patient Engagement & Adherence Platforms for Pharma
Description
This report benchmarks how tier-1 pharma companies are deploying agentic AI to personalize patient journeys, predict adherence risk, and scale 1:1 engagement across therapy areas. The report examines patient non-adherence economics (costing pharma $290B annually), real-world evidence of AI-driven engagement effectiveness, vendor landscape evolution, and implementation requirements. Key findings include AI platform capabilities (journey orchestration, predictive analytics, real-time intervention), compliance-by-design architecture, and ROI metrics. The report provides a roadmap for pharma leaders to evaluate platforms, pilot programs, and scale patient engagement at enterprise level.
Table of Contents
36 Pages
- EXECUTIVE SUMMARY
- 1.1 Methodology & Patient Engagement Landscape
- 1.2 The Adherence Crisis: $290B Annual Cost Opportunity
- 1.3 AI-Driven Engagement: Capabilities & Commercial Impact
- PATIENT ENGAGEMENT MATURITY ASSESSMENT
- 2.1 Four Stages: From Static Communications to Agentic AI Orchestration
- 2.2 Technology Capabilities: CDP, Journey Orchestration, Predictive Analytics
- 2.3 Governance & Compliance-First Architecture
- 2.4 Peer Benchmarking (Top Pharma Patient Programs)
- STRATEGIC IMPERATIVES FOR 2026
- 3.1 Moving Beyond Static Journeys: Real-Time Behavioral Response
- 3.2 Predictive Adherence Risk Detection & Early Intervention
- 3.3 Multi-Channel Personalization: Context-Aware Messaging
- 3.4 Outcome Measurement: Adherence, Persistence & Clinical Impact
- 3.5 Privacy-First Design: Consent, HIPAA, State Privacy Laws
- AI-POWERED PATIENT ENGAGEMENT: BEST PRACTICES
- 4.1 Agentic AI Models: Autonomous Decision-Making Within Compliance Bounds
- 4.2 Real-Time Personalization: Timing, Messaging, Channel Selection
- 4.3 Patient Data Integration: Unifying EHR, Claims, Patient-Reported Data
- 4.4 Case Study: Novartis Patient Support Program Excellence
- 4.5 Case Study: Roche Digital Patient Journey Transformation
- PLATFORM SELECTION & IMPLEMENTATION
- 5.1 Vendor Landscape & Platform Evaluation Matrix
- 5.2 Build vs. Buy: When to Partner vs. Develop In-House
- 5.3 Integration Patterns: API Strategy, Data Architecture
- 5.4 Pilot Program Design & Success Metrics
- 18-MONTH IMPLEMENTATION ROADMAP
- 6.1 Phase 1 (Months 1-6): Platform Selection & Pilot Launch
- 6.2 Phase 2 (Months 7-12): Expansion & Multi-Indication Rollout
- 6.3 Phase 3 (Months 13-18): Enterprise Scale & Continuous Optimization
- 6.4 Budget, Team Structure & Risk Management
- APPENDICES
- A. Patient Engagement Maturity Self-Assessment
- B. Vendor Evaluation Matrix (Platform Comparison)
- C. Compliance Checklist (HIPAA, Privacy, Consent)
- D. Implementation Roadmap (Gantt, Budget, KPIs)
- E. ROI Calculator (Adherence Improvement Scenarios)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

